Microsomal epoxide hydrolase gene polymorphism and susceptibility to colon cancer

British Journal of Cancer

Volumn 79, Issue 1, 1999, Pages 168-171

  Harrison, D J ^a   Hubbard, A L ^a   MacMillan, J ^a   Wyllie, A H ^a   Smith, C A D ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Cancer risk; Colon cancer; Epoxide hydrolase; Polymorphism

Indexed keywords

ARGININE; EPOXIDE HYDROLASE; HISTIDINE; MICROSOME ENZYME; PROTEIN P53; TYROSINE;

ADULT; ARTICLE; CANCER STATISTICS; CANCER SUSCEPTIBILITY; COLON CANCER; CONTROLLED STUDY; DNA POLYMORPHISM; EXON; GENOTYPE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; ONCOGENE K RAS; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

ADOLESCENT; ADULT; AGED; BASE SEQUENCE; COLONIC NEOPLASMS; DNA PRIMERS; EPOXIDE HYDROLASES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MICROSOMES; MIDDLE AGED; POLYMORPHISM, GENETIC; RNA PROCESSING, POST-TRANSCRIPTIONAL; TRANSCRIPTION, GENETIC;

EID: 0032889543     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6690028     Document Type: Article

References (23)

1. Brockmoller J, Cascorbi I, Kerb R and Roots I (1996) Combined analysis of inherited polymorphisms in arylamine N-acetyltransferase 2, glutathione S-transferases M1 and T1, microsomal epoxide hydrolase, and cytochrome p450 enzymes as modulators of bladder cancer risk. Cancer Res 56: 3915-3925
2. Cantlay AM, Smith CAD, Wallace WA, Yap P-L, Lamb D and Harrison DJ (1994) Heterogeneous and polymorphic expression of glutathione S-transferases in human lung. Thorax 49: 1010-1014
3. Cantlay AM, Lamb D, Gillooly M, Norrman J, Morrison D, Smith CAD and Harrison DJ (1995) Association between the CYP1A1 gene polymorphism and susceptibility to emphysema and lung cancer. J Clin Mol Pathol 48: M210-214
4. Chenevix-Trench G, Young J, Coggan M and Board O (1995) Glutathione S-transferase M1 and T1 polymorphisms: susceptibility to colon cancer and age of onset. Carcinogenesis 16: 1655-1657
5. Craft JA, Bulleid NJ, Jackson MR and Burchell B (1988) Induction of microsomal epoxide hydrolase by nitrosamines in rat liver. Effect on messenger ribonucleic acids. Biochem Pharmacol 37: 297-302
6. Cripps KJ, Purdie CA, Carder PJ, White S, Komine K, Bird CC and Wyllie AH (1994) A study of the stabilisation of p53 protein versus point mutation in colorectal carcinoma. Oncogene 9: 2739-2743
7. Giovannucci E and Willett WC (1994) Dietary factors and risk of colon cancer. Ann Med 26: 443-452
8. Hassett C, Aicher L, Sidhu LA and Omiecinski CJ (1994) Human microsomal epoxide hydrolase: genetic polymorphism and functional expression in vitro of amino acid variants. Hum Mol Genet 3: 421-428
9. Hassett C, Lin J, Carty CL, Laurenzana EM and Omiecinski CJ (1997) Human hepatic microsomal epoxide hydrolase: comparative analysis of polymorphic expression. Arch Biochem Biophys 337: 275-283
10. Hubbard AL, Harrison DJ, Moyes C, Wyllie AH, Cunningham C, Mannion E and Smith CAD (1997) N-acetyltransferase 2 genotype in colorectal cancer and selective gene retention in cancers with chromosome 8p deletions. Gut 41: 229-234
11. Illett KF, Ingram DM, Carpenter DS, Teitel CH, Lang NP, Kadlubar FF and Minchin RF (1994) Expression of monomorphic and polymorphic N-acetyltransferases in human colon. Biochem Pharmacol 47: 914-917
12. Kotsinas A, Spandidos DA, Romanowski P and Wyllie AH (1993) Relative expression of wild-type and activated Ki-ras2 oncogene in colorectal carcinomas. Int J Oncol 3: 841-845
13. Lancaster JM, Brownlee HA, Bell DA, Futreal PA, Marks JR, Berchuck A, Wiseman RW and Taylor JA (1996) Microsomal epoxide hydrolase polymorphism as a risk factor for ovarian cancer. Mol Carcinog 17: 160-162
14. Lang NP, Chu DZJ, Hunter CF, Kendall DC, Flammang TJ and Kadlubar FF (1986) Role of aromatic amine N-acetyltransferase in human colorectal carcinoma. Arch Surg 121: 1259-1261
15. Omiecinski CJ, Aicher L, Holubkov R and Checkoway H (1993) Human peripheral lymphocytes as indicators of microsomal epoxide hydrolase activity in liver and lung. Pharmacogenetics 3: 150-158
16. Probst-Hensch NM, Haile RW, Ingles SA, Longnecker MP, Han C, Lin BK, Lee DB, Sakamoto GT, Frankl HD, Lee ER and Lin HJ (1995) Acetylation polymorphism and prevalence of colorectal adenomas. Cancer Res 55: 2017-2020
17. Smith CAD and Harrison DJ (1997) Association between polymorphism in gene for microsomal epoxide hydrolase and susceptibility to emphysema. Lancet 350: 630-633
18. Strange RC, Matharoo B, Faulder GC, Jones P, Cotton W, Elder JB and Deakin M (1991) The human glutathione S-transferases: a case control study of the incidence of the GST1 0 phenotype in patients with adenocarcinoma. Carcinogenesis 12: 23-28
19. Tomlinson I, Ilyas M and Novelli M (1997) Molecular genetics of colon cancer. Cancer Metastasis Rev 16: 67-79
20. Wohlleb JC, Hunter CF, Blass B, Kadlubar FF, Chu DZJ and Lang NP (1990) Aromatic amine acetyltransferase as a marker for colorectal cancer: environmental and demographic associations. Int J Cancer 46: 22-30
21. Yang SK (1988) Sterioselectivity of cytochrome p-450 isozymes and epoxide hydrolase in the metabolism of polycyclic aromatic hydrocarbons. Biochem Pharmacol 37: 61-70
22. Yang EK, Radominska A, Winder BS and Dannenberg AJ (1993) Dietary lipids coinduce xenobiotic metabolising enzymes in rat liver. Biochim Biophys Acta 1168: 52-58
23. Zhong S, Wyllie AH, Barnes D, Wolf CR and Spurr NK (1993) Relationship between the GSTM1 genetic polymorphism and susceptibility to bladder, breast and colon cancer. Carcinogenesis 14: 1821-1824